Pluristem Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PSTI and buy or sell other stocks, ETFs, and their options commission-free!About PSTI
Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions.
CEOYaky Yanay, CPA
CEOYaky Yanay, CPA
Employees127
Employees127
HeadquartersHaifa, Haifa
HeadquartersHaifa, Haifa
Founded2001
Founded2001
Employees127
Employees127
PSTI Key Statistics
Market cap31.43M
Market cap31.43M
Price-Earnings ratio-0.99
Price-Earnings ratio-0.99
Dividend yield—
Dividend yield—
Average volume53.46K
Average volume53.46K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$7.13
52 Week high$7.13
52 Week low$2.88
52 Week low$2.88
Stock Snapshot
Pluristem Therapeutics(PSTI) stock is priced at $3.85, giving the company a market capitalization of 31.43M. It carries a P/E multiple of -0.99.
During the trading day, Pluristem Therapeutics(PSTI) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Pluristem Therapeutics(PSTI) stock has reached 0, versus its average volume of 53.46K.
Over the past 52 weeks, Pluristem Therapeutics(PSTI) stock has traded between a high of $7.13 and a low of $2.88.
Over the past 52 weeks, Pluristem Therapeutics(PSTI) stock has traded between a high of $7.13 and a low of $2.88.